Issued Patents All Time
Showing 25 most recent of 47 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12202911 | Multispecific antibody comprising CD137 binding domain and PDL1 binding domain | Tea Gunde, Sebastian Meyer, Matthias Brock, Christian Hess, Alexandre Simonin +1 more | 2025-01-21 |
| 12098203 | Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA | Tea Gunde, Sebastian Meyer, Christian Hess, Alexandre Simonin | 2024-09-24 |
| 11879005 | Hetero-dimeric multi-specific antibody format | Sebastian Meyer | 2024-01-23 |
| 11858981 | Humanization of rabbit antibodies using a universal antibody framework | Leonardo Borras | 2024-01-02 |
| 11578123 | Stable and soluble antibodies inhibiting TNFα | Leonardo Borras, Tea Gunde | 2023-02-14 |
| 11427628 | Antibody frameworks | Sebastian Meyer | 2022-08-30 |
| 11421035 | Stable antibody variable domain framework combinations and methods of use thereof | Dania DIEM, Christian Hess, Sebastian Meyer | 2022-08-23 |
| 11319371 | Anti-CD3 antibodies | Tea Gunde, Christian Hess, Sebastian Meyer, Alexandre Simonin, Teddy BELTRAMETTI | 2022-05-03 |
| 11236150 | Hetero-dimeric multi-specific antibody format | Sebastian Meyer | 2022-02-01 |
| 11046757 | Solubility optimization of immunobinders | Leonardo Borras | 2021-06-29 |
| 10781268 | Method for decreasing immunogenicity | Leonardo Borras | 2020-09-22 |
| 10590193 | Stable and soluble antibodies inhibiting VEGF | Leonardo Borras, Tea Gunde | 2020-03-17 |
| 10570198 | Stable and soluble antibodies | Leonardo Borras | 2020-02-25 |
| 10221237 | Solubility optimization of immunobinders | Leonardo Borras | 2019-03-05 |
| 10174102 | Antibody frameworks | Sebastian Meyer | 2019-01-08 |
| 10100111 | Stable and soluble antibodies inhibiting TNF alpha | Leonardo Borras, Tea Gunde | 2018-10-16 |
| 10087244 | Humanization of rabbit antibodies using a universal antibody framework | Leonardo Borras | 2018-10-02 |
| 10077312 | CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseases | Tea Gunde, Sebastian Meyer | 2018-09-18 |
| 9938336 | Sequence based engineering and optimization of single chain antibodies | Leonardo Borras | 2018-04-10 |
| 9908940 | Humanized immunobinders of cell-surface antigens | Valerie Hulmann-Cottier | 2018-03-06 |
| 9908945 | Sequence based engineering and optimization of single chain antibodies | Leonardo Borras | 2018-03-06 |
| 9873737 | Stable and soluble antibodies inhibiting VEGF | Leonardo Borras, Tea Gunde | 2018-01-23 |
| 9803027 | Method for decreasing immunogenicity | Leonardo Borras | 2017-10-31 |
| 9683034 | Stable and soluble antibodies inhibiting TNFα | Stefan Ewert, Adrian Auf Der Maur, Alcide Barberis, Peter Lichtlen | 2017-06-20 |
| 9598487 | Stable and soluble antibodies | Leonardo Borras | 2017-03-21 |